John A. Curran
Michigan State University(US)
Publications by Year
Research Areas
Bladder and Urothelial Cancer Treatments, Cancer Genomics and Diagnostics, Cancer Cells and Metastasis, Urinary and Genital Oncology Studies, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing(2013)2,153 cited
- → Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies(2012)862 cited
- → Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapy(2013)147 cited
- → A High Frequency of Activating Extracellular Domain ERBB2 ( HER2 ) Mutation in Micropapillary Urothelial Carcinoma(2013)136 cited
- → Relapsed Classic E-Cadherin ( CDH1 )–Mutated Invasive Lobular Breast Cancer Shows a High Frequency of HER2 ( ERBB2 ) Gene Mutations(2013)133 cited
- → Molecular characteristics of non-small cell lung cancer(2001)111 cited
- → Epithelial membrane protein-1 is a biomarker of gefitinib resistance(2005)88 cited
- → β-2-Microglobulin Is an Androgen-Regulated Secreted Protein Elevated in Serum of Patients with Advanced Prostate Cancer(2007)64 cited
- → Identification of TDE2 gene and its expression in non‐small cell lung cancer(2003)30 cited
- → Use of next-generation sequencing (NGS) to identify actionable genomic alterations (GA) in diverse solid tumor types: The Foundation Medicine (FMI) experience with 2,200+ clinical samples.(2013)6 cited